{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T20:26:48Z","timestamp":1777580808499,"version":"3.51.4"},"reference-count":5,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2020,11,4]],"date-time":"2020-11-04T00:00:00Z","timestamp":1604448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Ophthalmology"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To describe a novel surgical treatment option for managing a symptomatic filtration bleb extending into the three quadrants with adequate IOP control after Xen gel stent implantation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A 62-year-old female with pseudoexfoliative glaucoma with an IOP of 34\u2009mmHg underwent implantation of a Xen to reduce the IOP in her right eye. The IOP responded well to the procedure, but the patient developed a persistent giant filtration bleb with foreign body sensation and pain. A huge filtering bleb of over 180\u00b0 after Xen implant surgery was managed by splitting the giant bleb into two parts, posterior dissection into the intermuscular space, a biodegradable collagen device implantation, and suturing the conjunctiva in two parts with absorbable and nonabsorbable sutures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Before the operation for treatment of a giant bleb, the patient had an IOP of 12\u2009mmHg, a best-corrected visual acuity (BCVA) of 20\/40, corneal dellen, and no antiglaucoma medication. Following the bleb recession procedure, the IOP was 16\u2009mmHg, BCVA improved to 20\/20, there were no corneal dellen and the patient reported resolution of her bleb discomfort. The IOP and BCVA remained stable through 18\u2009months of follow-up and no antiglaucoma medications or additional surgical procedures were required.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The novel technique described here can be one option to treat this rare (over 180\u00b0) bleb formation after Xen Gel Stent implantation without adversely affecting IOP control.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/1120672120969040","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T02:45:42Z","timestamp":1604544342000},"page":"709-711","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["A novel surgical technique for the treatment of a filtration bleb extending over 180\u00b0 after Xen gel stent implantation"],"prefix":"10.1177","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0808-2250","authenticated-orcid":false,"given":"Juha","family":"V\u00e4lim\u00e4ki","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, PHHYKY, Lahti, Finland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2020,11,4]]},"reference":[{"key":"bibr1-1120672120969040","doi-asserted-by":"publisher","DOI":"10.1097\/IJG.0000000000001140"},{"key":"bibr2-1120672120969040","doi-asserted-by":"publisher","DOI":"10.1186\/s12886-019-1249-0"},{"issue":"11","key":"bibr3-1120672120969040","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.oftal.2015.03.003","volume":"90","author":"Fern\u00e1ndez-Garc\u00eda A","year":"2015","journal-title":"Arch Soc Esp Oftalmol"},{"key":"bibr4-1120672120969040","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.13717"},{"key":"bibr5-1120672120969040","doi-asserted-by":"publisher","DOI":"10.1111\/ceo.13335"}],"container-title":["European Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1120672120969040","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1120672120969040","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1120672120969040","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T19:43:42Z","timestamp":1777405422000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1120672120969040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,4]]},"references-count":5,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1177\/1120672120969040"],"URL":"https:\/\/doi.org\/10.1177\/1120672120969040","relation":{},"ISSN":["1120-6721","1724-6016"],"issn-type":[{"value":"1120-6721","type":"print"},{"value":"1724-6016","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,4]]}}}